JAJames A. Anderson

James A. Anderson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


James A. Anderson has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Andrew Stillwell

    Brisbane Orthopaedic and Sports Medicine Centre, Level 6 Brisbane Private Hospital, 259 Wickham Terrace, Brisbane, QLD, Australia

    1 shared publication
  • B. Halliday

    Orthopaedic Department, Royal Brisbane and Women's Hospital, Herston, Qld, Australia

    1 shared publication
  • Craig Engstrom

    School of Electrical Engineering and Computer Science, School of Human Movement and Nutrition Sciences, University of Queensland, Brisbane, Australia

    1 shared publication
  • James L. Gale

    Department of Epidemiology, University of Washington Seattle, WA

    1 shared publication
  • Jane A. Mason

    Queensland Haemophilia Centre, Department of Haematology and BMT, Royal Brisbane and Women's Hospital, Herston Queensland, Australia

    1 shared publication
  • Janet Kay Bobo

    Department of Preventive and Societal Medicine, University of Nebraska Medical Center, Omaha 68198-4350

    1 shared publication

Latest Publications

  • Predicting Anterior Cruciate Ligament Reconstruction Revision Risk

    by Jon A. Anderson, Mikko S. Venäläinen, Martin Lind, Craig Engstrom

    Background: Predicting anterior cruciate ligament reconstruction (ACLR) revision risk using machine learning (ML) regression analyses of large-scale registry data offers an evidence-based approach for clinical decision-making and management at a patient-specific level. We examined the performance of an enhanced ML-Cox regression analysis of the Danish Knee Ligament Reconstruction Registry (DKRR) for predicting ACLR revision risk. Methods: We analyzed surgical and patient-reported outcome measure data from 18,753 patients in the DKRR who underwent primary ACLR between 2005 and 2023. Enhanced ML-Cox regression analyses, using the least absolute shrinkage and selection operator (LASSO) and stable iterative variable selection (SIVS) approaches, were applied to predict the risk of ACLR revision (i.e., the risk of repeat surgery to reconstruct the ACL). The SIVS procedure identified key variables, including age at the time of primary ACLR and several Knee injury and Osteoarthritis Outcome Score (KOOS) items from 12-month follow-up surveys, as inputs for the best-performing regression models for predicting ACLR revision risk. The resultant Cox regression models for the prediction of ACLR revision risk, therefore, did not involve an analysis of patients with incomplete 12-month follow-up survey data, including patients with graft ruptures within 12 months after the primary surgery. Results: The best-performing Cox regression model for predicting ACLR revision risk incorporated age at the time of primary ACLR and 3 KOOS items (Pain P1 and Quality of Life Q2 and Q3) from the 12-month postoperative follow-up assessment. This model demonstrated good prediction accuracy 1, 2, and 5 years after the 12-month follow-up assessment (C-index [and standard error], 0.73 [0.03], 0.73 [0.02], and 0.74 [0.02], respectively). This 4-variable Cox regression model was well-calibrated across these time points. An online clinical point-of-care tool, the Danish KOOS3 Risk Monitoring Tool (DK3), was developed for predicting ACLR revision risk. Conclusions: Enhanced ML-Cox regression, incorporating patient age and 3 KOOS items obtained 12 months postoperatively, provided good prediction accuracy for ACLR revision risk from 1 to 5 years after the 12-month follow-up assessment, a period that has been associated with the vast majority of ACLR revisions. The newly developed DK3 point-of-care tool offers a direct-input method to predict and monitor the risk of ACLR revision. Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.


  • Open Access

    Open Repair of Intrameniscal Cysts With Fibrin Clot Augmentation

    by Jon A. Anderson, Peter T. Myers

    Cysts involving the meniscus are commonly identified on magnetic resonance imaging (MRI) of the knee. Most meniscal cysts are defined as parameniscal cysts created by synovial fluid extravasation through a tear in the meniscus into the adjacent soft tissues. Intrameniscal cysts are less common and do not extend to the articular surface. These cysts represent a management dilemma for the treating clinician, where established guidelines do not exist. Surgical management of intrameniscal cysts is based on initial diagnostic arthroscopy, confirming the absence of an intra‐articular tear, which would otherwise be treated in the standard manner based on tear characteristics. An open approach to the affected side is made with an “L‐shaped” capsulotomy performed to expose the peripheral meniscus. The meniscus is then incised transversely, and the degenerate tissue debrided with a curette and rasp. An autologous fibrin clot is prepared and placed in the defect and held with absorbable sutures. Patients with recalcitrant symptoms with a positive clinical examination and an MRI demonstrating intermediate signal without a tear should be considered for diagnostic arthroscopy and open repair. Failure to recognize this subset of meniscal cysts can lead to falsely negative arthroscopic assessments, resulting in untreated pain and mechanical symptoms. Technique Video: video See video under supplementary data.

  • Open Access

    Fibrin clot augmentation of high-risk meniscal repairs may result in clinical healing in up to 90% of cases

    by Peter S.E. Davies, Michael Goldberg, Jon A. Anderson, John Dabis, Andrew Stillwell, Timothy J. McMeniman, Peter T. Myers


  • Clinical outcomes and patient satisfaction following total hip and knee arthroplasty in patients with inherited bleeding disorders: A 20‐year single‐surgeon cohort

    by J. A. Anderson, J. A. Mason, B. Halliday

    Introduction: Persons with haemophilia and other inherited bleeding disorders are prone to disabling joint arthropathy frequently requiring arthroplasty for end‐stage joint disease. Higher complication rates and more modest post‐operative functional outcomes have previously been described.Aim: To evaluate the clinical outcomes and patient satisfaction of persons with inherited bleeding disorders (predominantly haemophilia) undergoing total hip and knee replacement.Methods: Retrospective, single‐centre cohort study with longitudinal assessment of patients with inherited bleeding disorders who underwent total hip and knee replacement over a 20‐year period. Eligible patients were clinically assessed with Harris Hip Score (HHS), Knee Society Score (KSS), pain visual analogue scale (VAS) and a patient satisfaction questionnaire.Results: Thirty‐one patients (48 joints) met the inclusion criteria. Mean age at surgery was 49.3 years (SD: 13.1, range 21‐75 years) with a mean follow‐up of 9.33 years (1.7‐19.3). The majority (26/31) of patients had haemophilia A, predominantly severe haemophilia A (22/26). Reported pain levels were low, and patient satisfaction was high. Joint‐specific outcome scores were “good” to “excellent” in 67% of total hip replacement patients and 92% of total knee replacement patients. A low complication rate was observed, with 2 patients requiring revision surgery and 4 patients requiring re‐operation without implant revision.Conclusion: Arthroplasty is a reliable procedure in patients with inherited bleeding disorders with end‐stage hip or knee arthropathy. The overall complexity of this group is highlighted, and the need for multidisciplinary care is emphasised.


  • Open Access

    Neuroethical issues in clinical neuroscience research

    by James A. Anderson, Marleen Eijkholt, Judy Illes


  • Acute Encephalopathy and Seizure Rates in Children under Age Two Years in Oregon and Washington State

    by Janet Kay Bobo, Purushottam B. Thapa, James A. Anderson, James L. Gale

    A surveillance network was established in Oregon and Washington state to identify cases of certain neurologic illnesses during a one-year period (August 1, 1987 to July 31, 1988) among children 1–24 months of age. Reported here are the observed case occurrence rates and findings from capture-recapture analyses used to predict rates that would have been observed had ascertainment been complete. The network consisted of a hospital component involving 98% of all eligible facilities, a provider component involving 93% of all eligible pediatricians and neurologists, and a research staff component of record abstractors. Of 3,876 potential cases reported, 626 met the study criteria. The observed rates for the primary diagnostic groups were: encephalopathies, 16 per 100,000 children; infantile spasms, 10 per 100,000 children; afebrile seizures, 159 per 100,000 children; and complex febrile seizures, 101 per 100,000 children. Of the 626 qualifying cases, 41% were reported by two or more surveillance components. Capture-recapture analyses with log-linear modeling to control for source dependence suggested 80% of all study cases were detected. Comparable percentages for the four illness groups were: encephalopathies, 82%; infantile spasms, 94%; afebrile seizures, 69%; and complex febrile seizures, 91%. The predicted rate for afebrile seizures, corrected for under-ascertainment, exceeded the upper 95% confidence interval bound around the observed rate. For all other conditions, predicted rates fell within the 95% confidence intervals around the observed rates. These findings suggest capture recapture analyses should be applied to the full sample of cases and to relevant disease substrata. Am J Epidemiol 1994;140:27–38.